These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

115 related articles for article (PubMed ID: 1767746)

  • 1. ANCA: a class of vasculitis-associated autoantibodies against myeloid granule proteins: clinical and laboratory aspects and possible pathogenetic implications.
    Goldschmeding R; Tervaert JW; Dolman KM; von dem Borne AE; Kallenberg CG
    Adv Exp Med Biol; 1991; 297():129-39. PubMed ID: 1767746
    [No Abstract]   [Full Text] [Related]  

  • 2. Significance of autoantibodies to purified proteinase 3 in systemic vasculitis.
    Gaskin G; Turner AN; Ryan JJ; Rees AJ; Pusey CD
    Adv Exp Med Biol; 1993; 336():287-9. PubMed ID: 8296619
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The pathogenic role of antineutrophil cytoplasmic autoantibodies.
    Ewert BH; Jennette JC; Falk RJ
    Am J Kidney Dis; 1991 Aug; 18(2):188-95. PubMed ID: 1651049
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA and associated diseases: immunodiagnostic and pathogenetic aspects.
    Gross WL; Schmitt WH; Csernok E
    Clin Exp Immunol; 1993 Jan; 91(1):1-12. PubMed ID: 8419069
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fundamental and clinical aspects of anti neutrophil cytoplasmic antibodies (ANCA).
    Hagen EC; Ballieux BE; Daha MR; van Es LA; Van der Woude FJ
    Autoimmunity; 1992; 11(3):199-207. PubMed ID: 1533316
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of proteinase 3 purified by reverse phase HPLC to detect autoantibodies in systemic vasculitis.
    Gaskin G; Kendal H; Coulthart A; Turner N; Pusey CD
    J Immunol Methods; 1995 Mar; 180(1):25-33. PubMed ID: 7897245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Antineutrophil cytoplasmic antibodies: a new diagnostic tool].
    Papo T; Meyer O; Piette JC
    Rev Med Interne; 1991; 12(1):60-5. PubMed ID: 2041916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antineutrophil cytoplasmic autoantibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences.
    Hagen EC; Ballieux BE; van Es LA; Daha MR; van der Woude FJ
    Blood; 1993 Apr; 81(8):1996-2002. PubMed ID: 8471761
    [No Abstract]   [Full Text] [Related]  

  • 9. Diverse target antigens recognized by circulating antibodies in anti-neutrophil cytoplasm antibody-associated renal vasculitides.
    Savige JA; Gallicchio M; Georgiou T; Davies DJ
    Clin Exp Immunol; 1990 Nov; 82(2):238-43. PubMed ID: 1978702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perinuclear antineutrophil cytoplasmic antibodies (p-ANCA): clinical significance and relation to antibodies against myeloid lysosomal enzymes.
    Tervaert JW; Mulder AH; Kallenberg CG
    Adv Exp Med Biol; 1993; 336():253-6. PubMed ID: 8296614
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Anti-neutrophil cytoplasmic autoantibodies (ANCA): antigenic specificities and clinical associations.
    Bosch X; Font J; Mirapeix E; Revert L; Urbano-Márquez A; Ingelmo M
    Adv Exp Med Biol; 1993; 336():281-6. PubMed ID: 8296618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical features and outcome in patients with glomerulonephritis and antineutrophil cytoplasmic autoantibodies.
    Gans RO; Kuizinga MC; Goldschmeding R; Assmann K; Huysmans FT; Gerlag PG; Donker AJ; Hoorntje SJ
    Nephron; 1993; 64(2):182-8. PubMed ID: 8321348
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of biologically active antineutrophil cytoplasmic antibodies induced in mice. Pathogenetic role in experimental vasculitis.
    Tomer Y; Gilburd B; Blank M; Lider O; Hershkoviz R; Fishman P; Zigelman R; Meroni PL; Wiik A; Shoenfeld Y
    Arthritis Rheum; 1995 Oct; 38(10):1375-81. PubMed ID: 7575687
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic antibodies (ANCA) and vasculitis.
    Kallenberg CG
    Clin Rheumatol; 1990 Mar; 9(1 Suppl 1):132-5. PubMed ID: 2168304
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.
    Holland M; Takada K; Okumoto T; Takahashi N; Kato K; Adu D; Ben-Smith A; Harper L; Savage CO; Jefferis R
    Clin Exp Immunol; 2002 Jul; 129(1):183-90. PubMed ID: 12100039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to selected minor target antigens in patients with anti-neutrophil cytoplasmic antibodies (ANCA).
    Talor MV; Stone JH; Stebbing J; Barin J; Rose NR; Burek CL
    Clin Exp Immunol; 2007 Oct; 150(1):42-8. PubMed ID: 17614969
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of antineutrophil cytoplasmic autoantibodies in diagnosing vasculitis in a Chinese patient population.
    Li PK; Leung JC; Lai FM; Wang A; Lui SF; Leung CB; Lai KN
    Am J Nephrol; 1994; 14(2):99-105. PubMed ID: 7915885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA--pathophysiology revisited.
    Kallenberg CG; Brouwer E; Mulder AH; Stegeman CA; Weening JJ; Tervaert JW
    Clin Exp Immunol; 1995 Apr; 100(1):1-3. PubMed ID: 7697907
    [No Abstract]   [Full Text] [Related]  

  • 19. Low predictive value of c-ANCA and anti-alpha-granule antibody for vasculitis in Hong Kong.
    Lawton JW; Lee SS
    Adv Exp Med Biol; 1993; 336():295-8. PubMed ID: 8296620
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Membrane surface proteinase 3 expression and intracytoplasmic immunoglobulin on neutrophils from patients with ANCA-associated vasculitides.
    Csernok E; Schmitt WH; Ernst M; Bainton DF; Gross WL
    Adv Exp Med Biol; 1993; 336():45-50. PubMed ID: 8296655
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.